All News #Library
Biotech
Vyriad Secures $25M To Advance In Vivo CAR T Candidate To Clinic
23 Dec 2025 //
BUSINESSWIRE
Vyriad Unveils Lead In Vivo CAR-T VV169 at ASH 2025
16 Dec 2025 //
BUSINESSWIRE
Vyriad, Weizmann Sign License Pact For Gene Delivery Technology
02 Sep 2025 //
PHARMAWEB
Novartis taps Vyriad’s viral vectors for in vivo T cell editing
20 Nov 2024 //
FIERCE BIOTECH
Vyriad Partners with Novartis to Develop In Vivo CAR-T Therapies
20 Nov 2024 //
PR NEWSWIRE

Market Place
Sourcing Support